OCUPHIRE PHARMA INC has a total of 13 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are GUANGDONG P D PHARMACEUTICAL CO LTD, AMARIN DEV AB and RED HILL BIOPHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Meyer Alan | 8 |
#2 | Pitlick William H | 4 |
#3 | Sooch Mina | 4 |
#4 | Charizanis Konstantinos | 4 |
#5 | Meyer Alan R | 4 |
#6 | Hoffmann Bernhard | 3 |
#7 | Alan Meyer | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020087021A1 | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders | |
WO2020081562A1 | Methods and compositions for treatment of glaucoma and related conditions | |
EP2950648A1 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | |
AU2014212275A1 | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |